title: Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
authors.affiliation: Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Cencini
authors.affiliation: Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Fabbri
authors.affiliation: Haematology Unit, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
authors.forename: Monica
authors.initials: M
authors.lastname: Bocchia
mesh_terms: D000328:Adult; D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000494:pharmacology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use*; D001761:Bleomycin / Q000494:pharmacology / Q000627:therapeutic use; D003606:Dacarbazine / Q000494:pharmacology / Q000627:therapeutic use; D004317:Doxorubicin / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000494:pharmacology / Q000627:therapeutic use*; D014747:Vinblastine / Q000494:pharmacology / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000074322:Antineoplastic Agents, Immunological; D001761:Bleomycin; D000069283:Rituximab; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: Hodgkin lymphoma; chemosensitivity; lymphoid malignancies; therapy